ABT Financials
Abbott Laboratories - Financial statements & key metrics
Stock Price
$116.35
Market Cap
$202.50B
P/E Ratio
31.3
EPS
$3.72
Income Statement Highlights
Most Recent Quarter: FY
Revenue
$44.33B
Gross Profit
$25.01B
Operating Income
$8.05B
Net Income
$6.52B
EPS (Diluted)
$3.72
Balance Sheet Highlights
Total Assets
$86.71B
Total Liabilities
$86.71B
Shareholders Equity
$52.13B
Cash & Equivalents
$8.52B
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$9.57B
CapEx
$2.17B
Free Cash Flow
$11.74B
Profitability Metrics
Gross Margin
56.7%
Operating Margin
0.2%
Net Margin
0.1%
ROE
0.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ABT revenue?
ABT's most recent quarterly revenue was $44.33B. Annual revenue can be calculated by summing the four most recent quarters.
Is ABT profitable?
ABT reported a profit of $6.52B in the most recent quarter. The net profit margin is 0.1%.
What is ABT market cap?
ABT has a market capitalization of $202.50B, making it a mega-cap stock.
Does ABT have debt?
View ABT's balance sheet for debt information.
What is ABT cash flow?
ABT's most recent quarterly free cash flow was $11.74B.